amoxicillin
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
7135
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
July 05, 2025
Effectiveness and Safety of First-Line Non-Bismuth Quadruple Concomitant Therapy Versus Single-Capsule Bismuth Quadruple Therapy.
(PubMed, Aliment Pharmacol Ther)
- "Sc-BQT is more effective, better tolerated, and more broadly applicable than 14-day CT. Both regimens achieved ≥ 90% success, but Sc-BQT's stewardship-friendly profile further supports its use as first-line therapy for H. pylori eradication."
Journal • Infectious Disease
July 04, 2025
On paper; in practice: measuring compliance with official pricing policies in a large field study of essential medicines in Indonesia.
(PubMed, J Pharm Policy Pract)
- "Five essential medicines (allopurinol, amlodipine, amoxicillin, cefixime, dexamethasone) were purchased from randomly selected health facilities, retail pharmacies and online outlets in Indonesia. Rules restricting permitted MRPs for unbranded generics, irrational since their inception, while they never set any limits at all on the price of branded medicines. This showed not enough evidence that the policy contributed to its objective of ensuring affordability."
Compliance • Journal • Pricing
July 03, 2025
Prevalence and antimicrobial susceptibility of Salmonella enterica Typhi in febrile patients: a cross-sectional study.
(PubMed, J Infect Dev Ctries)
- "Azithromycin and carbapenem were a suitable empirical therapy choice. However, the isolates were highly resistant to conventional first-line antibiotics (ampicillin, amoxicillin), second generation fluoroquinolones (ciprofloxacin), and third-generation cephalosporins (ceftriaxone, cefotaxime), that are considered vital in typhoid treatment."
Journal • Observational data • Retrospective data • Infectious Disease
July 03, 2025
Cost of non-antimicrobials for prophylaxis in the management of recurrent UTIs.
(PubMed, Scott Med J)
- "Trimethoprim was the cheapest of the antimicrobials for 6 months of prophylaxis (£5.08), followed by Cefalexin (£7.97), Amoxicillin (£10.71) and Nitrofurantoin (£16.32).ConclusionThe cost of antimicrobial management options for the prophylaxis of UTIs was found to be generally cheaper across the board, in comparison to non-antimicrobial products. However, the continuing public health crisis with regards to overprescribing of antimicrobials, growing resistance and the need for antimicrobial stewardship makes non-antimicrobials an ever-important consideration."
Journal
July 03, 2025
Whole-Genome Sequencing and Bioinformatics Analysis of ESBL- producing Klebsiella pneumoniae in a Ghanaian teaching hospital.
(PubMed, BMC Microbiol)
- "This study highlights the prevalence of MDR ESBL-producing K. pneumoniae in both hospital environments and patients, emphasizing the potential for cross-transmission within healthcare settings. These findings reinforce the urgent need for strengthened infection prevention and control measures, enhanced antimicrobial stewardship, and continuous genomic surveillance to mitigate the spread of resistant K. pneumoniae in healthcare settings."
Journal • Infectious Disease • Pneumonia • ACO1
July 03, 2025
Effect of therapeutic plasma exchange on amoxicillin, clindamycin, midazolam, and morphine pharmacokinetics in a critically ill child.
(PubMed, Pediatr Nephrol)
- "Despite theoretical predictions, clinically significant reductions in plasma drug concentrations of amoxicillin, clindamycin, and midazolam were observed following therapeutic plasma exchange. This case report emphasizes the necessity of therapeutic drug monitoring to adjust dosing appropriately and optimize patient outcomes."
Journal • PK/PD data • Critical care • Septic Shock
July 03, 2025
Antibiotics use and ethnoveterinary practices in pig farming: an insight from federal capital territory, Nigeria.
(PubMed, BMC Vet Res)
- "Antibiotic use was widespread, 90% of farmers administered antibiotics, with oxytetracycline, penicillin, and amoxicillin being most commonly used. Addressing these issues may support sustainable livestock production and AMR mitigation in similar low-and middle-income settings. These findings add to the understanding of antimicrobial practices in localised settings which cumulatively influence the global AMR burden."
Journal
July 03, 2025
Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
(clinicaltrials.gov)
- P4 | N=688 | Completed | Sponsor: Yongquan Shi | Recruiting ➔ Completed
Head-to-Head • Trial completion • Dyspepsia • Gastric Cancer • Gastroenterology • Gastrointestinal Disorder • Infectious Disease • Oncology • Peptic Ulcer • Solid Tumor
July 03, 2025
Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication
(clinicaltrials.gov)
- P4 | N=558 | Completed | Sponsor: Xijing Hospital of Digestive Diseases | Not yet recruiting ➔ Completed | Trial completion date: Oct 2025 ➔ Jun 2025 | Trial primary completion date: Sep 2025 ➔ Apr 2025
Trial completion • Trial completion date • Trial primary completion date • Gastrointestinal Disorder • Infectious Disease
July 02, 2025
Prevalence and antimicrobial resistance patterns of nontyphoidal Salmonella in Ghana: a systematic review and meta-analysis.
(PubMed, Trop Med Health)
- "Despite ongoing interventions, NTS remains a significant public health challenge in Ghana, with high AMR levels. The continued rise in resistance to critical antibiotics highlights the need for a One Health approach, improved diagnostics, enhanced surveillance, and targeted public health measures to control NTS and mitigate AMR."
Journal • Retrospective data • Review • Infectious Disease
July 02, 2025
Feasibility of serial measurement of nitrite for pharmacodynamic monitoring and precision prescribing in urinary tract infections.
(PubMed, Commun Med (Lond))
- "Here we show that nitrite generation by E. coli may have clinical relevance as a biomarker for infection progression and antimicrobial treatment outcomes, offering a valuable tool for monitoring the pharmacodynamic responses to antimicrobial therapy in UTIs."
Journal • PK/PD data • Infectious Disease • Nephrology
July 02, 2025
Recommendations and Adjuvant Therapies to Mitigate Clarithromycin-Resistant Helicobacter pylori-Associated Infections in Africa.
(PubMed, Infect Drug Resist)
- "In Africa, first-line therapy combines antimicrobials (eg, amoxicillin and clarithromycin) with proton pump inhibitors (PPIs), whereas second-line therapies (levofloxacin-based triple therapy, sequential non-bismuth quadruple therapy, or bismuth-based quadruple therapy) combine antimicrobials (amoxicillin, clarithromycin, nitroimidazole, levofloxacin, or tetracycline) with PPIs and bismuth compounds. The recommendations included the implementation of prevention measures, standardized antimicrobial susceptibility testing methods, strengthening the surveillance, and promoting antimicrobial stewardship, while phytotherapy and probiotics were discussed as potential adjuvant therapies to conventional antimicrobial treatments. While awaiting the full implementation of these measures, the treatment of H. pylori infections should be based on the guidelines of the AHMSG First Lagos Consensus."
Journal • Review • Gastric Cancer • Infectious Disease • Oncology • Solid Tumor
July 02, 2025
What is the appropriate antibiotic administration to prevent MRONJ development after tooth extraction?
(PubMed, J Bone Miner Metab)
- "A single preoperative dose of AMPC may be sufficient for tooth extractions in patients on low-dose BPs. However, teeth with radiopaque changes around the root require careful monitoring postextraction."
Journal
July 02, 2025
Azithromycin as adjunctive treatment for uncomplicated severe acute malnutrition (AMOUR): study protocol for a double-masked randomised controlled trial.
(PubMed, BMJ Open)
- P4 | "Amoxicillin is recommended for children with uncomplicated severe acute malnutrition (SAM). The results of this study will be disseminated to the Ministry of Health, community stakeholders and via peer-reviewed publications and academic conferences. NCT06010719."
Clinical • Clinical protocol • Journal
July 02, 2025
Efficient Sulfamethoxazole Removal by an Isolated Strain Microbacterium esteraromaticum S13.
(PubMed, Curr Microbiol)
- "The results showed that the strain can tolerate high SMX concentrations up to 150 mg/L and achieved the best removal efficiency at 35 °C, pH 8.0, with an initial SMX concentration of 100 mg/L and the addition of 5 g/L glucose, achieving a removal efficiency of 50.31% within 72 h. The strain also showed good removal potential for other sulfonamide antibiotics (SAs), including sulfadiazine, sulfamethazine, and sulfadimidine, with removal efficiencies all exceeding 61%, and also demonstrated a removal efficiency of 53% for amoxicillin. Nearly 100% removal of 100 mg/L SMX was achieved within 24 h, and S13-immobilized gel beads maintained a degradation rate of over 85% even after four consecutive rounds of degradation. These results strongly demonstrated the potential of the S13 strain to degrade antibiotics and provided a solid foundation for advancing the removal of SAs in the environment."
Journal
July 01, 2025
Novel Animal Model of Enterobacteria Pathogenicity, Virulence, and Amoxicillin-Biosurfactant Synergic Using Nsombé (Rhynchophorus phoenicis Larvae).
(PubMed, Microbiologyopen)
- "In contrast, amoxicillin alone demonstrated variable and less sustained efficacy. These findings underscore the potential of R. phoenicis larvae as a valuable alternative model for exploring host-pathogen interactions and assessing the synergistic efficacy of combined antimicrobial treatments involving antibiotics and biosurfactants."
Journal • Preclinical • Infectious Disease • Pneumonia • HSPD1
July 01, 2025
Anti-Inflammatory and Antibacterial Properties of Curcuma longa Extract Against Helicobacter pylori.
(PubMed, Mol Nutr Food Res)
- "In vitro experiments demonstrated that CLE completely inhibited the growth of H. pylori Sydney strain 1 (SS1) in a dose-dependent manner and exhibited synergistic effects when combined with amoxicillin...Furthermore, CLE attenuated inflammatory cell infiltration in the gastric mucosa of infected mice and significantly reduced the expression of proinflammatory cytokines and matrix metalloproteinases in H. pylori-infected AGS cells, a human gastric cancer cell line. These findings suggest that CLE is a promising candidate for the treatment of H. pylori infection, exhibiting potent antibacterial and anti-inflammatory properties."
Journal • Gastric Cancer • Gastrointestinal Disorder • Infectious Disease • Inflammation • Oncology • Peptic Ulcer • Solid Tumor
July 01, 2025
Trends in Antimicrobial Resistance of Major Mastitis-Causing Pathogens: A Nine-Year Study.
(PubMed, Vet Med Sci)
- "This study highlighted key factors contributing to MDR in mastitis pathogens. The findings emphasised the complex nature of antimicrobial resistance and the necessity for tailored strategies-such as improved farm management, seasonal interventions, and targeted antimicrobial use-to effectively mitigate resistance."
Journal • Retrospective data
July 01, 2025
Adsorptive Removal of Amoxicillin Using Green-Synthesized SiNH2@FeNP Nanocomposite: Characterization, Optimization, and Modeling.
(PubMed, ACS Omega)
- "These results demonstrate the high potential of SiNH2@FeNP as a low-cost, eco-friendly adsorbent for pharmaceutical removal from water, providing a scalable and sustainable alternative for wastewater treatment applications. This approach represents a novel combination of green nanotechnology and statistical optimization for AMX removal."
Journal
July 01, 2025
Antimicrobial Sensitivity Pattern of Sputum and Nasopharyngeal Swab in Children with Cystic Fibrosis: A Lesson from a Specialized Shishu (Children) Hospital in Bangladesh.
(PubMed, Mymensingh Med J)
- "In contrast, nearly all isolates were resistant to amoxicillin, erythromycin and rifampicin. Levofloxacin is the most effective agent to treat CF patients. Active surveillance of the resistance pattern should always continue to be promoted."
Journal • Observational data • Cystic Fibrosis • Genetic Disorders • Immunology • Infectious Disease • Pediatrics • Pneumonia • Pulmonary Disease • Respiratory Diseases
July 01, 2025
Gastroenterologists' perspectives of high-dose dual therapy for Helicobacter pylori infection in China: Results of a China survey.
(PubMed, Medicine (Baltimore))
- "Amoxicillin was the most commonly used antibiotic in HDDT, followed by clarithromycin, furazolidone, levofloxacin, metronidazole, cefuroxime and tetracycline. HDDT maybe the main treatment of H pylori eradication, but the application of the HDDT among gastroenterologists in China is insufficient. Better education should be carried out in future to improve the ability of gastroenterologists to standardize the treatment of H pylori infection."
Journal • Gastroenterology • Infectious Disease
June 28, 2025
Drug-induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Ten-year Retrospective Study of 103 Cases.
(PubMed, Clin Exp Dermatol)
- "In our study, carbamazepine, levofloxacin, ibuprofen, aspirin, amoxicillin, metronidazole and lamotrigine were the most common triggers for SJS/TEN. If combined with high-risk factors such as pneumonia, renal insufficiency, gastro-intestinal disorder, cardiac involvement and sepsis, SJS/TEN patients might have a higher risk of mortality."
Journal • Retrospective data • Gastroenterology • Gastrointestinal Disorder • Hepatology • Infectious Disease • Liver Failure • Nephrology • Pneumonia • Renal Disease • Respiratory Diseases • Septic Shock • Steven-Johnson Syndrome
June 28, 2025
Improving ratiometric-based analysis via designing intense bi-ligand metal-organic frameworks: dual-mode for detection of amoxicillin in milk and pharmaceutical samples.
(PubMed, Food Chem)
- "The spectrofluorometric method achieved a detection range of 5.0-250 μM with a detection limit of 0.34 μM, while the smartphone-based approach reached a detection limit of 3.3 μM. The BiL-Eu-MOF demonstrated high accuracy (98.1-102.7 %) and precision (RSD < 2 %) in milk and pharmaceutical samples, highlighting its potential as a simple, effective, and modification-free sensing platform."
Journal
June 27, 2025
Microbiota profiles and antimicrobial resistance genes in sow fecal samples from farms with and without antibiotic use.
(PubMed, Anim Biosci)
- "Sows were randomly divided into two groups: one was fed a commercial diet with antibiotics for 3 weeks from mating to day 21 of gestation, before the farrowing stage (amoxycillin 300 mg/kg and tiamulin 150 mg/kg: control group, ABO), and the other was fed the same diet without antibiotics (treatment group, NOABO)...Our investigations discovered that the core microbiota of withdrawal antibiotics may be related to the gut microbiota and AMR. Therefore, understanding the gut microbiota composition and function in animals could enable strategies for its modulation to improve sows' gut microbiota and minimize the negative impact of antibiotics."
Journal
June 27, 2025
Genetically Engineered Yeast for Enhanced Biodegradation of Β-lactam Antibiotics.
(PubMed, Appl Biochem Biotechnol)
- "Over 90% of 10 µM ampicillin was degraded within 0.5 h using 250 nM α-factor and a cultivation period of 24 h. Finally, the transferability to other β-lactam antibiotics was investigated, resulting in complete degradation of amoxicillin, penicillin G and piperacillin within 24 h."
Journal
1 to 25
Of
7135
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286